By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Oncology
Vaccines





Company News
TapImmune Inc. (TPIV) Provides Update On Polystart™ Vaccine Platform Applicable To Cancer And Infectious Disease 10/22/2014 7:41:11 AM
TapImmune Inc. (TPIV) CEO Provides Update On Corporate Activity And Progression Of Clinical Programs 9/23/2014 10:48:54 AM
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial Of Folate Receptor Alpha Antigens In Ovarian And Breast Cancer 9/16/2014 8:55:22 AM
TapImmune Inc. (TPIV) Announces $2 Million Registered Direct Offering 8/11/2014 10:42:10 AM
TapImmune Inc. (TPIV)'s New Clinical Trial In Advanced Stage Ovarian Cancer Expands The Use Of Folate Receptor Alpha Peptide Antigens 8/7/2014 11:08:05 AM
TapImmune Inc. (TPIV) Prevails In Legal Dispute With Michael Gardner 7/24/2014 10:53:30 AM
TapImmune Inc. (TPIV) Appoints Leading Immunotherapy Researcher to Chair Scientific Advisory Board 6/13/2014 7:29:08 AM
TapImmune Inc. (TPIV) Is Pleased To Provide An Update On Corporate Events And Milestones For 2014 4/3/2014 9:54:47 AM
TapImmune Inc. (TPIV) Is Pleased To Announce The Filing Of New Intellectual Property Surrounding Its Novel And Proprietary Platform Expression System Polystart™ 3/20/2014 10:12:31 AM
TapImmune Inc. (TPIV) Is Pleased To Announce The Signing Of An Exclusive Option Agreement For A New Phase 1 Clinical Program In Breast And Ovarian Cancer 3/19/2014 9:02:38 AM
1234567
//-->